The FDA is expected to decide on treatments for bullous pemphigoid, hereditary angioedema, HIV PrEP, ovarian cancer, and RSV.

Managing complex medication schedules could soon become as simple as taking a single capsule each day. Engineers at the ...

The repercussions of the USG shift on the global HIV commodity markets should not be underestimated in the medium term. Sustained predictability in HIV commodity demand forecasts is essential to ...

Autism is a neurodevelopmental condition. Someone may have social and communication differences, sensory issues and/or ...

The University of Illinois Chicago’s free, drop-in Community Outreach Intervention Program (COIP) is using harm reduction strategies to protect the health and wellbeing of community members struggling ...

Two new ways of giving the HIV medicine Dolutegravir to newborn babies have been found to be safe and effective, according to ...

Long-acting injectable antiretroviral therapy (ART) can be administered at home to persons living with HIV as safely and ...

Florida recorded 681 cases of TB in 2024, about 9% more than the previous year, federal data shows. California had the highest number of reported TB cases in 2024, with 2,100 cases. More than 30 other ...

The US Food and Drug Administration has approved nipocalimab-aahu, a new FcRn- blocking monoclonal antibody, for the ...

Missouri is reportedly one of the last states that has not yet legalized needle or syringe exchange programs. These programs ...

Real-world data indicated ART with DTG+3TC was effective and well tolerated among patients with HIV infection regardless of prior ART exposure.

Tackling HIV continues to be a major public health challenge, mainly because the persistence of viral reservoirs means that ...